25.02.2020
Swissmedic authorises a new active substance (NAS) under the ACSS Consortium initiative for the first time
25.02.2020
Befristete Bewilligung zum Vertrieb in französischer Aufmachung
12.02.2020
Chargenrückruf aufgrund von nicht konformen Resultaten in der Stabilitätsstudie bis auf Stufe Detailhandel
12.02.2020
Befristete Bewilligung zum Vertrieb in finnischer Aufmachung
11.02.2020
Die im Firmenschreiben erwähnten Chargen bis auf Stufe Patient
In focus
Information concerning the new EU-Regulations as well as their implementation in Switzerland.
Direct links
Communications regarding the safety of medicines
Select from the list…
HPC/DHPC
Publication of safety measures (FSCA)
Product groups, services
Select from the list…
Authorised narcotics
Authorisations
Penal Law
Certificates
Legal matters
Stay up to date
Our news subscription service provides on-going information via e-mail.
Incident reporting
Medicines
Reporting undesirable effects
Medical devices
Reporting incidents & FSCAs
Featured
04.12.2018
The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
For further information...
